Indolocarbazoles and the use thereof
    7.
    发明授权
    Indolocarbazoles and the use thereof 失效
    Indolocarbazoles及其用途

    公开(公告)号:US5043335A

    公开(公告)日:1991-08-27

    申请号:US557299

    申请日:1990-07-23

    CPC分类号: C07D498/22

    摘要: The present invention provides 9,10,11,12-tetrahydro-9,12-epoxy-1H-diindolo [1,2,3-fg: 3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1,3(2H)-dione and 9,10,11,12-tetrahydro-2-(tetrahydro-5-methoxy-2-furanyl) -9,12-epoxy-1H-diindolo[1,2,3-fg: 3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1,3(2H)-dione process for the preparation thereof, pharmaceutical compositions containing the compounds, and use of the compounds in heart and blood vessel diseases such as thromboses, arterioscleroses, hypertension and inflammatory diseases, allergies, cancer and certain degenerative damage of the central nervous system, as well as diseases of the immune system.

    摘要翻译: 本发明提供9,10,11,12-四氢-9,12-环氧-1H-二吲哚并[1,2,3-fg:3',2',1'-k]吡咯并[3,4-i ] [1,6]苯并二氮辛啶-1,3(2H) - 二酮和9,10,11,12-四氢-2-(四氢-5-甲氧基-2-呋喃基)-9,12-环氧基-1H-二吲哚 [1,2,3-fg:3',2',1'-kl]吡咯并[3,4-i] [1,6]苯并二氮杂辛基-1,3(2H) - 二酮制备方法 含有化合物的组合物,以及化合物在心血管疾病如血栓形成,动脉硬化症,高血压和炎性疾病,过敏症,癌症和中枢神经系统的某些退行性损伤以及免疫系统疾病中的用途。

    Indolocarbazole derivatives and the use thereof
    10.
    发明授权
    Indolocarbazole derivatives and the use thereof 失效
    吲哚咔唑衍生物及其用途

    公开(公告)号:US5489608A

    公开(公告)日:1996-02-06

    申请号:US382959

    申请日:1995-02-02

    IPC分类号: C07D487/14 A61K31/40

    CPC分类号: C07D487/14

    摘要: The present invention provides indolocarbazole derivatives of the formula ##STR1## as well as the regioisomeric mixtures thereof, pharmacologically acceptable salts thereof, processes for the preparation thereof, and pharmaceutical compositions containing them for the treatment and/or prophylaxis of heart and blood vessel diseases, such as thromboses, arterioscleroses, hypertonias, of bronchopulmonary diseases, inflammatory processes, allergies, cancers and degenerative damage of the central nervous system, and for the treatment of viral diseases.

    摘要翻译: 本发明提供式(I)的吲哚并咔唑衍生物及其区域异构体混合物,其药理学上可接受的盐,其制备方法和含有它们用于治疗和/或预防心脏和血液的药物组合物 血管疾病,如血栓形成,动脉硬化,支气管肺疾病的高渗,炎性过程,过敏,癌症和中枢神经系统的退行性损伤,以及病毒性疾病的治疗。